Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Byetta - First-in-Class Incretin Mimetic



Clinical trial results

Results from clinical trials reported to date suggest Exenatide is well tolerated.


Back to Project Details



Related Projects

Naproxcinod (HCT 3012) - COX-Inhibiting Nitric Oxide-Donator
Developed by French pharmaceutical company NicOx, naproxcinod (HCT 3012)...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Lyrica (Pregabalin) - New Gabapentinoid with Wide
Developed by Pfizer, pregabalin, marketed under the brand name Lyrica, is...

Xolair - Biological Therapy
The product of a joint development programme between Tanox, Genentech...

Acomplia (Rimonabant) - Investigational Agent for
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

See all projects

Related News

Once-Monthly Injectable Exenatide Improves Glucose Control in Study
Amylin Pharmaceuticals, Eli Lilly and Alkermes have reported positive...

See all news

Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.